(Q41500173)

1 October 2017

1 reference

title

Use of calcium antagonists in patients with ischemic heart disease and systemic hypertension (English)

1 reference

1 October 2017

main subject

coronary artery disease

1 reference

W H Frishman

1

1 reference

1 October 2017

M D Michaelson

series ordinal

2

1 reference

1 October 2017

language of work or name

English

0 references

publication date

1 May 1997

1 reference

American Journal of Cardiology

1 October 2017

published in

1 reference

1 October 2017

volume

79

1 reference

1 October 2017

issue

10A

1 reference

1 October 2017

page(s)

33-8; discussion 47-8

1 reference

Role of hypertension in atherosclerosis and cardiovascular disease

1 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900270-1

Rationale for calcium entry-blocking drugs in systemic hypertension complicated by coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900270-1

Left ventricular hypertrophy by electrocardiogram. Prevalence, incidence, and mortality in the Framingham study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900270-1

Precursors of sudden coronary death. Factors related to the incidence of sudden death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900270-1

7 January 2021

Calcium channel blockers

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900270-1

Vascular selective calcium entry blockers in the treatment of cardiovascular disorders: focus on felodipine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900270-1

Calcium-channel blockers for combined angina pectoris and systemic hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900270-1

Efficacy and safety of nisoldipine coat core in the management of angina pectoris, systemic hypertension, and ischemic ventricular dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900270-1

Nisoldipine coat core as concomitant therapy in chronic stable angina pectoris.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900270-1

Effects of nisoldipine therapy on myocardial perfusion and neuro-hormonal status in patients with severe ischaemic left ventricular dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900270-1

Comparison of oral propranolol and verapamil for combined systemic hypertension and angina pectoris. A placebo-controlled double-blind randomized crossover trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900270-1

Comparison of diltiazem and nifedipine for both angina pectoris and systemic hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900270-1

Efficacy and safety of sustained-release diltiazem as replacement therapy for beta blockers and diuretics for stable angina pectoris and coexisting essential hypertension: a multicenter trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900270-1

Calcium channel blockers in patients with both hypertension and angina pectoris.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900270-1

The Risk of Myocardial Infarction Associated With Antihypertensive Drug Therapies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900270-1

Nifedipine. Dose-related increase in mortality in patients with coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900270-1

Antihypertensive effect of cardiovascular Ca2+-antagonist in hypertensive patients in the absence and presence of beta-adrenergic blockade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900270-1

Long-term therapy of arterial hypertension with nifedipine given alone or in combination with a beta-adrenoceptor blocking agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900270-1

FDA gives calcium channel blockers clean bill of health but warns of short-acting nifedipine hazards

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900270-1

Calcium antagonists and mortality in patients with coronary artery disease: a cohort study of 11,575 patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900270-1

Final outcome results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS). A randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900270-1

Calcium channel blockers. Lessons learned from MIDAS and other clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900270-1

Prevalence of Hypertension in the US Adult Population : Results From the Third National Health and Nutrition Examination Survey, 1988-1991

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900270-1

Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900270-1

Doppler flow and echocardiography in functional cardiac insufficiency: assessment of nisoldipine therapy. Results of the DEFIANT-II Study. The DEFIANT-II Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900270-1

10.1016/S0002-9149(97)00270-1

7 January 2021

Identifiers

DOI

1 reference

1 October 2017

1 reference